Manuel A. Sepúlveda
- Immunology top 1%
- Oncology top 2%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- James P. AllisonSergio A. QuezadaFubin LiWelby Montalvo-OrtizJeffrey V. RavetchJake Y. HenryKatharina BergerhoffClaire Roddie
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Immunotherapy and Immune Responses (4 papers)Immune Cell Function and Interaction (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Manuel A. Sepúlveda
16 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Immunology 1.6k
- Oncology 1.5k
- Molecular Biology 486
- Radiology, Nuclear Medicine and Imaging 197
- Pulmonary and Respiratory Medicine 194
Countries citing papers authored by Manuel A. Sepúlveda
This map shows the geographic impact of Manuel A. Sepúlveda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel A. Sepúlveda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel A. Sepúlveda more than expected).
Fields of papers citing papers by Manuel A. Sepúlveda
This network shows the impact of papers produced by Manuel A. Sepúlveda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel A. Sepúlveda. The network helps show where Manuel A. Sepúlveda may publish in the future.
Co-authorship network of co-authors of Manuel A. Sepúlveda
This figure shows the co-authorship network connecting the top 25 collaborators of Manuel A. Sepúlveda. A scholar is included among the top collaborators of Manuel A. Sepúlveda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel A. Sepúlveda. Manuel A. Sepúlveda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancerbreakdown → | 455 |
| 3 | 1 | |
| 4 | 41 | |
| 5 | 44 | |
| 6 | Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapybreakdown → | 229 |
| 7 | Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanomabreakdown → | 1093 |
| 8 | 5 | |
| 9 | 6 | |
| 10 | 105 | |
| 11 | 39 | |
| 12 | 35 | |
| 13 | 49 | |
| 14 | 102 | |
| 15 | [Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1]. | 3 |
| 16 | 22 |
About Manuel A. Sepúlveda
Manuel A. Sepúlveda is a scholar working on Immunology, Oncology and Hepatology, having authored 16 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (1.5k citations) and Radiology, Nuclear Medicine and Imaging (197 citations). Manuel A. Sepúlveda has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include James P. Allison, Sergio A. Quezada, Fubin Li, Welby Montalvo-Ortiz, Jeffrey V. Ravetch, Jake Y. Henry, Katharina Bergerhoff, Claire Roddie, Karl S. Peggs and Jedd D. Wolchok. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.